The Food and Drug Administration has told food manufacturers the psychoactive mushroom Amanita muscaria isn’t authorized for food, including edibles, because it doesn’t meet safety standards.
psychedelics
Mushroom edibles are making people sick. Scientists still don’t know why
A wave of illnesses is bringing scrutiny to a murky marketplace of mushroom gummies and candy. But is a popular red-capped fungus really to blame? Testing shows there’s more going on
FDA gives thumbs down to MDMA for now, demanding further research
The much-anticipated decision has rattled supporters of psychedelic therapies. The drugmaker says it will ask the agency to reconsider.
More Americans are microdosing or tripping on magic mushrooms than ever
Two new studies estimate psychedelic use in the U.S. and both find magic mushrooms gaining in popularity, including some folks who just want to get a little bit high, aka microdosing.
Trouble for ecstasy? What MDMA’s FDA setback could mean for psychedelics
Psychedelics researchers and investors are still reeling from last week’s no vote for MDMA by a panel of advisers to the FDA.
As the FDA evaluates ecstasy treatment for PTSD, questions mount about the evidence
Clinical trials of MDMA have been promising, but concerns have emerged about the quality of the research. A June hearing scheduled by the Food and Drug Administration is likely to address them.


